Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-03-06

FDA Approved: BISMUTH SUBCITRATE POTASSIUM, METRONIDAZOLE AND TETRACYCLINE HYDROCHLORIDE — Supplemental Application (Endo USA, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Endo USA, Inc.'s generic fixed-dose combination of bismuth subcitrate potassium, metronidazole and tetracycline …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bismuth Subcitrate Potassium, Metronidazole and Tetracycline Hydrochloride (Bismuth Subcitrate Potassium; Metronidazole; Tetracycline Hydrochloride)

Snippet

SUPPL AP for BISMUTH SUBCITRATE POTASSIUM, METRONIDAZOLE AND TETRACYCLINE HYDROCHLORIDE (BISMUTH SUBCITRATE POTASSIUM, METRONIDAZOLE AND TETRACYCLINE HYDROCHLORIDE)